SCHEMBL5320132

SCHEMBL5320132

NC(C(=O)O)C(N)C1CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 10/20 0.45
SLC1A1 P43005 10/20 0.45
SLC1A3 P43003 7/20 0.45
SLC7A5 Q01650 1/20 0.42
ALOX5 P09917 1/20 0.37
PTGS1 P23219 1/20 0.35
SLC7A11 Q9UPY5 1/20 0.35
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
GRM8 O00222 1/20 0.33
GRM6 O15303 1/20 0.33
LMNA P02545 1/20 0.33
APEX1 P27695 1/20 0.33
GRM5 P41594 1/20 0.33
PMP22 Q01453 1/20 0.33
GRM1 Q13255 1/20 0.33
GRM2 Q14416 1/20 0.33
GRM3 Q14832 1/20 0.33
GRM4 Q14833 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24520309 0.88 SLC1A3 (0.50) SLC1A2SLC1A1SLC1A3GRM2
SCHEMBL22143593 0.79 SLC1A2 (0.45) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
SCHEMBL24411126 0.79 SLC1A2 (0.45) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
SCHEMBL31688910 0.77 SLC7A5 (0.40) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
SCHEMBL3450600 0.77 SLC7A5 (0.40) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
Hydrochloric Acid SCHEMBL22125733 0.77 SLC1A2 (0.44) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
Hydrochloric Acid SCHEMBL22125734 0.77 SLC1A2 (0.44) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
SCHEMBL1417103 0.75 SLC7A5 (0.50) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
SCHEMBL5322605 0.73 ALOX5 (0.38) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5
SCHEMBL5322602 0.73 ALOX5 (0.38) SLC1A2SLC1A1SLC1A3SLC7A5ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258899-A1 Diagnostic and therapeutic agents YBX1, MLX, TPX2 SLC1A2 4787/4885SLC1A1 4654/4885SLC1A3 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.